Latest Stock Market News

The leading global PE firm offloaded about 3.5% stake or 2.24 crore shares. Goldman Sachs, Morgan Stabley, Mirae Asset MF, Societe Generale, Citigroup, ICICI Pru MF bought stakes. Mutual funds have a significant 16.77% stake and foreign investors hold about 17.61% stake as of March 2024.

The Dow Jones Industrial Average fell 9.66 points, or 0.02%, at the open to 39,863.33.

State-owned Power Grid Corporation on Wednesday reported a nearly four per cent dip in its consolidated net profit to Rs 4,166.33 crore in the March 2024 quarter, mainly due to a marginal decline in income. The company reported a consolidated net profit of Rs 4,322.87 crore in the quarter ended on March 31, 2023, a BSE filing showed.

Rules mandate at least 20% of promoters’ shares to be locked in for a certain period of time post-listing after an IPO. This relaxation will help new-age technology companies as founders’ shareholding comes down usually after an IPO. Non-promoter shareholders excluding individuals holding more than 5% of the post-offer equity share capital can contribute towards the shortfall, Sebi said.

GE Power India on Wednesday posted a consolidated net profit of Rs 25.94 crore in March 2024 quarter on the back of higher revenue. The company had reported a loss of Rs 129.70 crore in the quarter ended on March 31, 2023, a BSE filing showed.

Nifty closes 69 points higher, forming a bullish candle with strong buying interest. Holding above 22,590, it may reach 22,750, supported by 22,500. Analysts anticipate further uptrend, with key support at 22,500 and resistance at 22,800.

Long unwinding refers to the selling of positions or stocks owned for a longer period either to book profit or to exit it in anticipation of impending bearishness.

Sensex advanced 267 points while Nifty closed higher for the fifth day in a row on Wednesday. Sectorally, buying was seen in utilities, energy, FMCG and realty while metal, banks, consumer durables and oil & gas stocks saw selling pressure. PNC Infratech rose over 13% to hit a fresh record high.

Indian generic injectables maker Gland Pharma reported fourth-quarter profit below estimates on Wednesday, as soaring employee expenses outweighed strong demand in its core markets.